House Instigators Work Outside the Spotlight

  WASHINGTON, DC - SEPTEMBER 10: during a "Exempt America from Obamacare" rally,  on Capitol Hill, September 10, 2013 in Washington, DC. Some conservative lawmakers are making a push to try to defund the health care law as part of the debates over the budget and funding the federal government. (Photo by Drew Angerer/Getty Images) WASHINGTON, DC - SEPTEMBER 10:during a "Exempt America from Obamacare" rally,  on Capitol Hill, September 10, 2013 in Washington, DC. Some conservative lawmakers are making a push to try to defund the health care law as part of the debates over the budget and funding the federal government.  
National Journal
Billy House
Oct. 2, 2013, 6:21 p.m.

The Sen­ate Re­pub­lic­ans whose ar­gu­ments helped drag Obama­care in­to the fund­ing de­bate are well-known. Sens. Ted Cruz of Texas and Mike Lee of Utah have gained much at­ten­tion.

But what about their coun­ter­parts in the House?

A small group of con­ser­vat­ive House mem­bers has had broad in­flu­ence over the fisc­al de­bate, help­ing to steer the ac­tions of Speak­er John Boehner and the Re­pub­lic­an con­fer­ence. And yet few of them have stepped in­to the na­tion­al spot­light.

“They meet secretly, they plot and they plan,” said Rep. Dev­in Nunes, R-Cal­if.

One of the most vis­ible is Rep. Tom Graves of Geor­gia, who got dozens of fel­low Re­pub­lic­ans to sup­port his ef­fort to de­fund Obama­care and who, along with Cruz and Lee, has been in­stru­ment­al in the push to use the fund­ing fight to weak­en the Af­ford­able Care Act. Oth­ers in­clude reg­u­lar mav­er­icks like Reps. Justin Amash of Michigan, Louie Gohmert of Texas, Tim Huel­skamp of Kan­sas, and Steve King of Iowa. There are also Reps. Paul Broun of Geor­gia, Thomas Massie of Ken­tucky, Steve Stock­man of Texas, and Ted Yoho of Flor­ida.

Minor­ity Lead­er Nancy Pelosi has called the House tea-party wing a bunch of “le­gis­lat­ive ar­son­ists” for their de­mands. Sen­ate Ma­jor­ity Lead­er Harry Re­id has called them “an­arch­ists.”

While few doubt there is a genu­ine hatred of the Af­ford­able Care Act and an an­ti­gov­ern­ment fer­vor among this group, some law­makers sug­gest that the budget battle was also de­signed as a vehicle to weak­en Boehner and help re­make the House Re­pub­lic­an Con­fer­ence it­self.

Rep. Mark Mead­ows, R-N.C., a tea-party-aligned mem­ber, said Wed­nes­day that he’s heard such sug­ges­tions about him­self and oth­ers who have played key in­stig­at­ing roles be­hind the House ef­fort to tie the dis­mant­ling of Obama­care to a bill that funds gov­ern­ment. And, in­deed, Mead­ows wrote a let­ter to his Re­pub­lic­an lead­ers this sum­mer sug­gest­ing that very strategy, also signed by dozens of col­leagues.

But Wed­nes­day, Mead­ows said talk that the idea was in­ten­ded to em­bar­rass or un­der­mine Boehner is un­true.

“I can tell you there’s been ab­so­lutely no con­ver­sa­tions about a new speak­er,” he said. “If any­thing, I’ve made just a great ap­peal to thank lead­er­ship in a united way.”

Nunes points out that many of the mem­bers in­volved in the Obama­care de­bate were part of the same group that “at­temp­ted this goofy thing right as we came out of the gate this year,” re­fer­ring to a botched ef­fort by some House law­makers to pre­vent Boehner from win­ning his second term as speak­er in Janu­ary. More than 20 House Re­pub­lic­ans were said to be be­hind that ef­fort — enough to keep Boehner from get­ting a re­quired ma­jor­ity-plus-one — but the re­bel­lion fizzled.

In the time since then, Nunes said, many have worked to pre­vent Boehner from get­ting enough votes in the House to pass le­gis­la­tion without hav­ing to turn to Demo­crats for help, which some might see as weak. He sug­gests a sim­il­ar strategy is in play on the budget im­passe now.

“So what was the real ob­ject­ive? A lot of these guys, when you talk to them privately, the guys who don’t let us get to 218 on any­thing, they’ll tell you, “˜Well, we just figured the lead­er­ship was go­ing to cave,’ “ Nunes said. He said their be­lief was that Boehner would cut a deal with Pres­id­ent Obama and Demo­crats, and by his do­ing so would fur­ther un­der­mine his stand­ing as speak­er.

“So now just step back from this — if they ac­tu­ally thought Boehner was go­ing to cave, that means they nev­er ac­tu­ally had a real plan to deal with the CR to be­gin with,” Nunes said. “From the be­gin­ning, this nev­er made sense.”

A Boehner spokes­man had no com­ment.

But an­oth­er House Re­pub­lic­an law­maker, speak­ing on the con­di­tion he not be named, said that Ma­jor­ity Lead­er Eric Can­tor and Ma­jor­ity Whip Kev­in Mc­Carthy, R-Cal­if., share part of the blame for the open­ness and brazen­ness with which some con­ser­vat­ives now openly defy the speak­er.

While there are few pub­lic con­front­a­tions with­in the lead­er­ship trio, he noted that both Can­tor and Mc­Carthy voted on New Year’s against the bill de­signed to avert the so-called fisc­al cliff, abandon­ing Boehner. The law­maker said that il­lus­trated for oth­ers that Boehner’s in­flu­ence could be chal­lenged.

“It’s one thing to sit at the lead­er­ship table and dis­agree and talk through things,” the law­maker said. “It’s an­oth­er to then leave the table and do so. And since the fisc­al cliff when you had No. 2 and No. 3 not back No. 1, every­body’s been say­ing, “˜Where are these guys?’ “

Mead­ows in­sists that what he and the oth­er con­ser­vat­ives be­hind the ef­fort to tie Obama­care to a CR are try­ing to ac­com­plish has noth­ing to do with oust­ing Boehner.

“We are united in this ef­fort to get gov­ern­ment back open and work­ing again. So, there’s been no talk of any­thing like that,” he said.

What We're Following See More »
GERMAN MINISTER SAYS U.S. WON’T COMPROMISE
U.S.-EU Trade Deal a Dead Letter for Now
59 minutes ago
THE LATEST

Sigmar Gabriel, the German economic minister, said there's no chance of the Transatlantic Trade and Investment Partnership being agreed upon before the U.S. elections this fall. Gabriel said the United States "had effectively ended talks" on the free trade deal with the European Union "because Washington had not wanted to compromise with its European counterparts."

Source:
DOWN FROM POST-CONVENTION NUMBERS
Monmouth Has Clinton Up Seven
1 hours ago
THE LATEST

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Source:
DEBATE PREP
Clinton Advisers Talking to Psychologists, Trump Ghostwriter
1 hours ago
THE LATEST

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

INFLUENCED BY NUKES, POLLUTION
Scientists Declare Dawn of Anthropocene Epoch
4 hours ago
WHY WE CARE

"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."

Source:
EPI-PEN PRICES
House Committee Investigating Mylan
4 hours ago
THE LATEST

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.

Source:
×